Browsing by Author "Vitola, João (6602072314)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial(2023) ;Karthikeyan, Ganesan (57188672173) ;Peix, Amalia (55899478200) ;Devasenapathy, Niveditha (23033698100) ;Jimenez-Heffernan, Amelia (55897520300) ;Haque, Saif-ul (57218168830) ;Rodella, Carlo (31067520000) ;Giubbini, Raffaele (7004319496) ;Rosas, Erick Alexanderson (57205709570) ;Ozkan, Elgin (7007024961) ;Keng, Yung Jih Felix (57942745400) ;Vitola, João (6602072314) ;Sobic-Saranovic, Dragana (57202567582) ;Soni, Manoj (57942104600) ;López, Leonardo (57941442200) ;Cabrera, Lázaro O. (14061659500) ;Camacho-Freire, Santiago (55515266200) ;Manovel-Sanchez, Ana (14520375700) ;Naeem, Hesham (57224600165) ;Fatima, Shazia (8331748200) ;Rinaldi, Roberto (57217700985) ;Carvajal-Juarez, Isabel (57203129644) ;Esenboga, Kerim (55965196800) ;Dondi, Maurizio (56789705600)Paez, Diana (54785022800)Background: In patients with multi-vessel disease presenting with ST elevation myocardial infarction (STEMI), the efficacy and safety of ischemia-guided, vs routine non-culprit vessel angioplasty has not been adequately studied. Methods: We conducted an international, randomized, non-inferiority trial comparing ischemia-guided non-culprit vessel angioplasty to routine non-culprit vessel angioplasty, following primary PCI for STEMI. The primary outcome was the between-group difference in percent ischemic myocardium at follow-up stress MPI. All MPI images were processed and analyzed at a central core lab, blinded to treatment allocation. Results: In all, 109 patients were enrolled from nine countries. In the ischemia-guided arm, 25/48 (47%) patients underwent non-culprit vessel PCI following stress MPI. In the routine non-culprit PCI arm, 43/56 (77%) patients underwent angioplasty (86% within 6 weeks of randomization). The median percentage of ischemic myocardium on follow-up imaging (mean 16.5 months) was low, and identical (2.9%) in both arms (difference 0.13%, 95%CI − 1.3%–1.6%, P <.0001; non-inferiority margin 5%). Conclusion: A strategy of ischemia-guided non-culprit PCI resulted in low ischemia burden, and was non-inferior to a strategy of routine non-culprit vessel PCI in reducing ischemia burden. Selective non-culprit PCI following STEMI offers the potential for cost-savings, and may be particularly relevant to low-resource settings. (CTRI/2018/08/015384). © 2022, The Author(s).
